The ERK pathway plays an important role in HL pathogenesis [52]-[54] and inhibition of the negative regulator DUSP5 might be important for proliferation and survival of tumor cells as indicated by the low expression of DUSP5 in the majority of tumor cells. This evidence concerns the gene DUSP5 and Hodgkins lymphoma.